|
|
| Striving toward new heights: The diverse experiences of Keenan's Henry R. Loubet offer comprehensive insight into healthcare | ||||||
|
|
||||||
When
you reach the summit, what do you do once you get there? Sit back and
enjoy the view? Or look for new mountains to conquer? After being
named senior vice president/chief strategy officer for Keenan, a
multi-line insurance brokerage and consulting firm in
At
Keenan, Loubet is responsible for product development, business
development, labor relations, marketing and overall corporate
strategy. He also is chairman of a Keenan subsidiary called Innovative
Care Services (ICS), that offers disability management,
leave-of-absence programs and return-to-work programs. In
1989, as senior vice president and regional executive of Health Net,
Loubet helped create one of Not
all of Loubet's ventures are limited to the healthcare field. After
purchasing some prime real estate in Loubet
also founded a non-profit golf program for disadvantaged youth called
Ace Kids Golf in 1989 that operates in "It's
been an exciting adventure," he says. "I take great pride in
the number of successes we have had with kids who did not even know
where to grab the golf club or who didn't know anything about the game
and have gone on to play golf in college. "In
all my professional and personally driven endeavors, whether it is
with the healthcare industry, non-profits or wine making, I am driven
by a genuine desire and passion to make a difference, to be a leader
and an innovator," Loubet says. Q.
Do you see a future in traditional HMO products? A.
HMO products are
time-tested relative to providing value and for the services
delivered, and really serve as the primary managed care product today,
along with PPOs, to millions of Americans in both the commercial
sector as well as Medicaid and Medicare. [HMOs] have a proven track
record in delivering cost-effective, high-quality care. In addition,
the recent Medicare reforms seem to have revitalized the HMO market,
and as the generation that 'grew up' in HMOs moves into retirement,
this kind of managed care delivery will continue to exist and be
popular with retirees. Ultimately, HMOs will continue to be a major
product in the insurance industry. Q.
What are your thoughts on consumer-directed care?
A.
Consumerism must be
viewed in a larger perspective, beyond only being a type of healthcare
product like consumer-directed health plans. It is about the
cultivation of tools, and the power of knowledge being wielded by
consumers to effectively operate within the provider delivery system
and to make the adjustments needed to affordably access the care they
need. It is the type of healthcare delivery that puts the consumer in
the center of the healthcare navigational experience. It focuses on
accountability, transparency and taking responsibility for one's
health. The consumer is much more directly impacted economically by
the decisions they make in accessing healthcare. Q.
What role will employers play in healthcare? Do you see more or fewer
employers embracing self-funding?
A.
Employers are
getting much more involved. Clearly, there is a lot of economic
pressure employers face with more of their revenue going to providing
health benefits. Certainly employer coalitions such as the Pacific
Business Group on Health and others have really gone a long way to try
to drive a lot of change and innovation around healthcare delivery.
They have tried to influence health plans and providers to be more
responsive in terms of transparency, accountability and financial
performance. The
cost escalation in healthcare is likely to increase the need for the
improved flexibility and innovation that self-funding provides for
employers in creating benefit designs and financial models that work
more efficiently for them. Self-funding provides a degree of
insulation from the trend of state mandates and specified plan
designs, which often lead to additional costs. Employers increasingly
want to have their own experience be the driver for the cost of these
benefit plans and thus more employers will embrace self-funding. Q.
Does transferring financial responsibility to patients with costly
diseases result in better or worse care?
A.
For cost-sharing to
be effective, we need to put measures in place to ensure that patients
continue to receive appropriate healthcare and pharmaceutical
benefits. I am definitely concerned with patients with severe and
costly diseases having to share a disproportionate financial
responsibility deterring them from receiving available healthcare
services and appropriate pharmaceutical interventions. I do believe,
however, that a reasonable level of patient financial responsibility
leads to cost-effective care and thus there is a balance that needs to
be achieved. Q.
How should we deal with high-cost biopharmaceuticals and emerging
technologies? A.
Specialty care
management programs will give rise to a new breed of pharmacy
management services that will focus on high-cost and emerging
biopharmaceuticals delivered in a more transparent and efficient
manner while ensuring appropriate and high-quality care. The time is
now to improve the way drug benefits and new technologies are
designed, provided and managed, with evidence-based criteria and
centers of excellence to ensure highest quality, effective healthcare
delivery at the appropriate cost. Q.
What are the key initiatives now underway that will grow exponentially
in the next year? A.
Pay-for-performance
[P4P], which promotes incentives to align the interests of various
healthcare stakeholders, has taken on great momentum nationwide.
Payment methods to physicians and hospitals include increasing payment
on P4P methodology, i.e., incentive payments tie financial rewards to
outcomes. Physicians are rewarded and paid based on the quality of
services provided, clinical outcomes, patient experience and
healthcare IT adoption and success—all in an effort to improve
quality, accountability and affordability for healthcare consumers. I
am a founding board member of the California-based Integrated
Healthcare Assn., considered the foremost leader in the field of P4P
organizations.
|